9.0 Research Involving Recombinant DNA

As a condition for NIH funding, all rDNA research conducted at or sponsored by the University, irrespective of the source of funding, must comply with the NIH Guidelines.  The NIH Guidelines defines rDNA as either (1) molecules that are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell or (2) molecules that result from the replication of those described in (1) above.  Non-compliance by a PI may result in (1) suspension, limitation or termination of financial assistance for the noncompliant NIH-funded research project and of NIH funds for other rDNA research at the institution or (2) a requirement for prior NIH approval of any or all recombinant DNA projects at the University.  In order to assure compliance, all PIs working with rDNA need to be familiar with the latest edition of the NIH Guidelines; an online course, NIH Guidelines for Research Involving Recombinant DNA, offered through EHS, has been developed to assist PIs in meeting this obligation.